Matteo Villa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Peritoneal Dialysis

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

High Throughput Sequencing

Top Venues

NPJ precision oncology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia (2024)
Diletta Fontana, Federica Malighetti, Matteo Villa, Alfonso Zambon, Carlo B Gambacorti-Passerini, Luca Mologni
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 38 (8) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Diletta Fontana, Ilaria Crespiatico, Valentina Crippa, Federica Malighetti, Matteo Villa, Fabrizio Angaroni, Luca De Sano, Andrea Aroldi, Marco Antoniotti, Giulio Caravagna, Rocco Giovanni Piazza, Alex Graudenzi, Luca Mologni, Daniele Ramazzotti
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. Nature communications 14 (1) (2023)
Andrea Aroldi, Mario Mauri, Daniele Ramazzotti, Matteo Villa, Federica Malighetti, Valentina Crippa, Federica Cocito, Chiara Borella, Elisa Bossi, Carolina Steidl, Chiara Scollo, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo B Gambacorti-Passerini
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia. Journal of cellular and molecular medicine (2023)
Matteo Villa, Geeta Geeta Sharma, Chiara Manfroni, Diego Luigi Cortinovis, Luca Mologni
New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)-Positive Cancer. Cancers 13 (20) (2021)
Giulia Arosio, Geeta Geeta Sharma, Matteo Villa, Mario Mauri, Ilaria Crespiatico, Diletta Fontana, Chiara Manfroni, Cristina Mastini, Marina Zappa, Vera Magistroni, Monica Ceccon, Sara Redaelli, Luca Massimino, Anna Garbin, Federica Lovisa, Lara Mussolin, Rocco Giovanni Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers 13 (17) (2021)